Sino Biopharmaceutical (HKSE:01177) Total Current Liabilities : HK$24,727 Mil (As of Dec. 2023)

Sino Biopharmaceutical Total Current Liabilities Chart

Sino Biopharmaceutical Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Total Current Liabilities		Get a 7-Day Free Trial					9,038.90	12,972.83	18,789.48	22,502.56	24,726.81

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Current Liabilities	Get a 7-Day Free Trial															18,789.48	19,066.40	22,502.56	29,384.87	24,726.81

Sino Biopharmaceutical Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Sino Biopharmaceutical's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Sino Biopharmaceutical's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Sino Biopharmaceutical Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (HKSE:01177) Business Description